Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses
PurposeWe aimed to assess the additional value of a radiomics-based signature for distinguishing between benign and malignant non-mass enhancement lesions (NMEs) on dynamic contrast-enhanced breast magnetic resonance imaging (breast DCE-MRI).MethodsIn this retrospective study, 232 patients with 247...
Main Authors: | Yan Li, Zhenlu L. Yang, Wenzhi Z. Lv, Yanjin J. Qin, Caili L. Tang, Xu Yan, Yihao H. Guo, Liming M. Xia, Tao Ai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.738330/full |
Similar Items
-
Radiomic Evaluations of the Diagnostic Performance of DM, DBT, DCE MRI, DWI, and Their Combination for the Diagnosisof Breast Cancer
by: Shuxian Niu, et al.
Published: (2021-09-01) -
Radiomics Nomogram of DCE-MRI for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer
by: Ning Mao, et al.
Published: (2020-10-01) -
3T DCE-MRI Radiomics Improves Predictive Models of Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Stefania Montemezzi, et al.
Published: (2021-04-01) -
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
by: Nathaniel M. Braman, et al.
Published: (2017-05-01) -
Radiomics Feature Activation Maps as a New Tool for Signature Interpretability
by: Diem Vuong, et al.
Published: (2020-12-01)